Unlocking the Power of GLP-1s

In the world of health and wellness, GLP-1 receptor agonists—like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—have skyrocketed in popularity for their remarkable weight-loss effects. But these medications, originally designed for type 2 diabetes, offer a treasure trove of benefits beyond shedding pounds. Emerging research reveals their potential to transform overall health, from easing sleep apnea to safeguarding the heart. As we dive into these advantages, it’s clear GLP-1s are reshaping preventive medicine.

One standout perk is improved sleep. Obstructive sleep apnea (OSA), often tied to obesity, disrupts rest with repeated breathing pauses. GLP-1s can reduce the apnea-hypopnea index, potentially lessening reliance on CPAP machines by promoting weight loss and direct airway benefits. For those with fatty liver disease (now called metabolic dysfunction-associated steatotic liver disease), these drugs shine brightly. They reduce liver fat accumulation and inflammation, helping reverse non-alcoholic fatty liver disease (NAFLD) in many cases.

Inflammation, a root cause of chronic illness, is another target. GLP-1s exhibit anti-inflammatory properties independent of weight loss, curbing cytokine production and easing systemic swelling in organs like the brain and gut. Heart protection is profound: Large trials show 12-26% reductions in major cardiovascular events, including heart attacks and strokes. They achieve this by lowering blood pressure (1-5 mmHg systolic drop), improving vascular function, and reducing inflammation.

Cholesterol profiles get a boost too, with better lipid balances—higher HDL and lower triglycerides—contributing to artery health. Blood pressure improvements further shield against hypertension-related risks.

How can you access these benefits close to home? At Summit Wellness Group, on the corner of Airport & Nelson, you work directly with an MD and RN to find the best option for you. Traditional prescriptions via insurance can cover brand-name GLP-1s for approved uses like diabetes, obesity, moderate or severe sleep apnea or heart disease, often at lower out-of-pocket costs when these criteria are met. Flexible dosing, microdosing, taking lower than the standard FDA starting doses, is gaining traction for metabolic health, insulin sensitivity, and fewer side effects. Options include compounded GLP-1s from LegitScript pharmacies, starting at $425-$525 per vial for home use or $525-$675 /month for in-office visits, with supplies included, including B12 shots, body scans and personalized treatment. We will guide you through the art of taking these medications to get you looking and feeling your best. The future of wellness might just be in these game-changers.